Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Kalincik, Tomas; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Grammond, Pierre; Onofrj, Marco; Lugaresi, Alessandra; ÖZAKBAŞ, SERKAN; Kappos, Ludwig; Kuhle, Jens; TERZİ, MURAT; Lechner-Scott, Jeannette; BOZ, CAVİT; Grand'Maison, Francois; Prevost, Julie; Sola, Patrizia; Ferraro, Diana; Granella, Franco; Trojano, Maria; Bergamaschi, Roberto; Pucci, Eugenio; Turkoglu, Recai; McCombe, Pamela; Van Pesch, Vincent; Van Wijmeersch, Bart; Solaro, Claudio; Ramo-Tello, Cristina; Slee, Mark; Alroughani, Raed; Yamout, Bassem; Shaygannejad, Vahid; Spitaleri, Daniele; Luis Sanchez-Menoyo, Jose; Ampapa, Radek; Hodgkinson, Suzanne; KARABUDAK, RANA; Butler, Ernest; Vucic, Steve; Jokubaitis, Vilija; Spelman, Tim; Butzkueven, Helmut

doi:10.1136/jnnp-2018-319831

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

Copy For Citation

Kalincik T., Havrdova E. K., Horakova D., Izquierdo G., Prat A., Girard M., ...More

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol.90, no.4, pp.458-468, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 90 Issue: 4
Publication Date: 2019
Doi Number: 10.1136/jnnp-2018-319831
Journal Name: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.458-468
Hacettepe University Affiliated: Yes

Abstract

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting multiple sclerosis. Direct comparison of their effect on relapse and disability is needed.